DEVELOPMENT OF A BROAD-SPECTRUM THERAPEUTIC

NIH RePORTER · NIH · N01 · $1,593,363 · view on reporter.nih.gov ↗

Abstract

To support the development of therapeutic products for use in post-event settings following the intentional release of a NIAID Category A, B, or C Priority Pathogen or in response to naturally occurring outbreaks of infectious diseases caused by the NIAID Category A, B, and C Priority Pathogens, including the conduct of a Phase I clinical trial.

Key facts

NIH application ID: 10207325
Project number: 272201600028C-P00011-9999-2
Recipient: ABVIRO, LLC
Principal Investigator: URBAN RAMSTEDT
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $1,593,363
Award type: —
Project period: 2016-09-23 → 2022-06-25